Valuation : Adocia

Market Cap 8.08Cr 9.39Cr 7.58Cr 6.93Cr 13Cr 887.38Cr 13Cr 90Cr 35Cr 453.49Cr 35Cr 34Cr 1.46TCr P/E 2026 *
-753x
P/E 2027 * 5.97x
Enterprise Value 5.09Cr 5.92Cr 4.78Cr 4.37Cr 8.16Cr 559.5Cr 8.23Cr 57Cr 22Cr 285.92Cr 22Cr 22Cr 920.86Cr EV / Sales 2026 *
20.2x
EV / Sales 2027 * 3.13x
Free-Float
96.05%
Yield 2026 *
-
Yield 2027 * -
1 day+0.10%
1 week+2.89%
Current month+3.51%
1 month+4.77%
3 months+0.54%
6 months-33.63%
Current year-38.39%
1 week 3.92
Extreme 3.92
4.17
1 month 3.92
Extreme 3.92
4.3
Current year 3.61
Extreme 3.61
7.45
1 year 3.61
Extreme 3.61
12.4
3 years 2.86
Extreme 2.86
12.66
5 years 2.74
Extreme 2.745
16.16
10 years 2.74
Extreme 2.745
61.9
Manager TitleAgeSince
Chief Executive Officer 55 11/05/2023
Director of Finance/CFO - 23/09/2024
Chief Tech/Sci/R&D Officer - 01/12/2014
Director TitleAgeSince
Director/Board Member 55 19/04/2013
Chairman 57 -
Director/Board Member 61 11/05/2023
Date Insider Type Main position Quantity % Market Cap. Importance
27/02/25 Buy

Founder

1,09,170 0.6972%
06/04/24 Buy

Founder

15,576 0.1105%
06/04/24 Buy

Founder

51,921 0.3685%
Change 5-day change 1-year change 3-year change Capi.($)
+0.10%+2.89%-49.60%-64.72% 9.35Cr
+0.41%-2.07%+41.26%+95.40% 6.89TCr
+1.31%+0.55%+49.48%+90.80% 6.53TCr
+0.04%+4.36%-11.72%+459.54% 2.77TCr
-0.90%-7.65%+2.45%-15.50% 2.61TCr
-2.45%-2.35%+40.19%+10.03% 2.58TCr
+1.01%+1.38%+26.48%-17.16% 2.01TCr
+3.45%-13.46%+222.69%+389.50% 1.7TCr
-0.36%-3.79%+0.73%+537.48% 1.5TCr
+1.03%+7.00%+59.98%+160.03% 1.45TCr
Average +0.36%-1.36%+38.19%+164.54% 2.8TCr
Weighted average by Cap. +0.42%-1.19%+42.96%+148.83%

Financials

2026 *2027 *
Net sales 25.22L 29.31L 23.66L 21.65L 40.41L 28Cr 40.73L 2.8Cr 1.09Cr 14Cr 1.1Cr 1.08Cr 46Cr 3.54Cr 4.11Cr 3.32Cr 3.04Cr 5.67Cr 388.93Cr 5.72Cr 39Cr 15Cr 198.76Cr 15Cr 15Cr 640.13Cr
Net income -43.17L -50.18L -40.51L -37.07L -69.18L -47Cr -69.73L -4.79Cr -1.87Cr -24Cr -1.88Cr -1.84Cr -78Cr -4.43Cr -5.15Cr -4.16Cr -3.81Cr -7.1Cr -487.02Cr -7.16Cr -49Cr -19Cr -248.89Cr -19Cr -19Cr -801.57Cr
Net Debt -2.98Cr -3.47Cr -2.8Cr -2.56Cr -4.78Cr -327.89Cr -4.82Cr -33Cr -13Cr -167.56Cr -13Cr -13Cr -539.66Cr 3.02Cr 3.51Cr 2.83Cr 2.59Cr 4.84Cr 331.54Cr 4.87Cr 33Cr 13Cr 169.43Cr 13Cr 13Cr 545.67Cr
Logo Adocia
Adocia is a biotechnology company that specializes in the development of innovative formulations of already-approved therapeutic proteins for the treatment of diabetes. At the end of 2025, the group had a portfolio of 4 products in clinical development (BioChaperone Lispro U100 and U200, BioChaperone Combo, M1Pram and BioChaperone Glucagon) and 4 preclinical-stage products (AdoShell® Islets, AdOral® Sema, AdoGel® Sema and BioChaperone® CagriSema).
Employees
73
Date Price Change Volume
03/26/03 €4.128 +0.10% 71,464
02/26/02 €4.124 +2.64% 1,12,895
01/26/01 €4.018 +0.75% 55,333
31/26/31 €3.988 -0.20% 46,017
28/26/28 €3.996 -0.40% 31,732
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
4.128EUR
Average target price
9.700EUR
Spread / Average Target
+134.98%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ADOC Stock